These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 15700122)
21. Evolving issues in the management of reflux disease? Yuan Y; Hunt RH Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644 [TBL] [Abstract][Full Text] [Related]
22. Update on Endoscopic Approaches for the Management of Gastroesophageal Reflux Disease. Nabi Z; Reddy DN Gastroenterol Hepatol (N Y); 2019 Jul; 15(7):369-376. PubMed ID: 31391807 [TBL] [Abstract][Full Text] [Related]
23. Predictors of heartburn resolution and erosive esophagitis in patients with GERD. Orlando RC; Monyak JT; Silberg DG Curr Med Res Opin; 2009 Sep; 25(9):2091-102. PubMed ID: 19601705 [TBL] [Abstract][Full Text] [Related]
24. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. Hassall E J Pediatr; 2005 Mar; 146(3 Suppl):S3-12. PubMed ID: 15758900 [TBL] [Abstract][Full Text] [Related]
25. The knife or the pill in the long-term treatment of gastroesophageal reflux disease? Lundell LR Yale J Biol Med; 1994; 67(3-4):233-46. PubMed ID: 7502532 [TBL] [Abstract][Full Text] [Related]
26. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease. Tack J Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988 [TBL] [Abstract][Full Text] [Related]
27. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders]. Issing WJ; Tauber S; Folwaczny C; Reichel O Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080 [TBL] [Abstract][Full Text] [Related]
28. [Insufficient symptom control under long-term treatment with PPI in GERD - fact or fiction?]. Labenz J; Labenz G; Stephan D; Willeke F; MMW Fortschr Med; 2016 May; 158 Suppl 4():7-11. PubMed ID: 27221555 [TBL] [Abstract][Full Text] [Related]
29. Current and future perspectives in the management of gastroesophageal reflux disease. Akiyama J; Kuribayashi S; Baeg MK; de Bortoli N; Valitova E; Savarino EV; Kusano M; Triadafilopoulos G Ann N Y Acad Sci; 2018 Dec; 1434(1):70-83. PubMed ID: 29766521 [TBL] [Abstract][Full Text] [Related]
32. Gastroesophageal reflux disease. Control of symptoms, prevention of complications. Kaynard A; Flora K Postgrad Med; 2001 Sep; 110(3):42-4, 47-8, 51-3. PubMed ID: 11570205 [TBL] [Abstract][Full Text] [Related]
33. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD. Frazzoni M; Conigliaro R; Manta R; Melotti G Aliment Pharmacol Ther; 2011 Jul; 34(1):67-75. PubMed ID: 21539587 [TBL] [Abstract][Full Text] [Related]
34. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. Bonavina L; Saino G; Bona D; Sironi A; Lazzari V J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355 [TBL] [Abstract][Full Text] [Related]
35. Antireflux Surgery in Korea: A Nationwide Study from 2011 to 2014. Lee JH; Park JM; Han SU; Kim JJ; Song KY; Ryu SW; Seo KW; Kim HI; Kim W; Gut Liver; 2016 Sep; 10(5):726-30. PubMed ID: 27114420 [TBL] [Abstract][Full Text] [Related]